Literature DB >> 16564444

Physics and imaging for targeting of oligometastases.

Fang-Fang Yin1, Shiva Das, John Kirkpatrick, Mark Oldham, Zhiheng Wang, Su-Min Zhou.   

Abstract

Oligometastases refer to metastases that are limited in number and location and are amenable to regional treatment. The majority of these metastases appear in the brain, lung, liver, and bone. Although the focus of interest in the past within radiation oncology has been on the treatment of intracranial metastases, there has been growing interest in extracranial sites such as the liver and lung. This is largely because of the rapid development of targeting techniques for oligometastases such as intensity-modulated and image-guided radiation therapy, which has made it possible to deliver single or a few fractions of high-dose radiation treatments, highly conformal to the target. The clinical decision to use radiation to treat oligometastases is based on both radiobiological and physics considerations. The radiobiological considerations involve improvement of treatment schema for time, dose, and volume. Areas of interests are hypofractionation, tumor and normal tissue tolerance, and hypoxia. The physics considerations for oligometastases treatment are focused mainly on ensuring treatment accuracy and precision. This article discusses the physics and imaging aspects involved in each step of the radiation treatment process for oligometastases, including target definition, treatment simulation, treatment planning, pretreatment target localization, radiation delivery, treatment verification, and treatment evaluation.

Entities:  

Mesh:

Year:  2006        PMID: 16564444     DOI: 10.1016/j.semradonc.2005.12.004

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  6 in total

1.  Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity?

Authors:  Tom Treasure
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Potential underestimation of the internal target volume (ITV) from free-breathing CBCT.

Authors:  Irina Vergalasova; Jacqueline Maurer; Fang-Fang Yin
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

3.  Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.

Authors:  Deepa A Rao; M Laird Forrest; Adam W G Alani; Glen S Kwon; Joseph R Robinson
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

4.  Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis.

Authors:  K A Paschos; N Bird
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

Review 5.  Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.

Authors:  Mohammed Yahia Almaghrabi; Stéphane Supiot; Francois Paris; Marc-André Mahé; Emmanuel Rio
Journal:  Radiat Oncol       Date:  2012-08-01       Impact factor: 3.481

Review 6.  Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization).

Authors:  Peter Hass; Konrad Mohnike
Journal:  Viszeralmedizin       Date:  2014-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.